Patient Leaflet Updated 15-Jul-2025 | Ferring Pharmaceuticals Ltd
Terlipressin Acetate 0.12 mg/ml solution for injection
Terlipressin Acetate 0.12 mg/ml solution for injection
1. What Terlipressin Acetate is and what it is used for
2. Before you are given Terlipressin Acetate
3. How you will be given Terlipressin Acetate
4. Possible side effects
5. How Terlipressin Acetate is stored
6. Contents of the pack and other information
Terlipressin Acetate is a ready‑to‑use solution for injection containing the active substance, Terlipressin acetate.
Terlipressin Acetate is used to treat `bleeding oesophageal varices’.
This is a serious and life-threatening problem.
When the medicine is injected into your bloodstream:
You must not be given Terlipressin Acetate if any of the above apply to you. If you are not sure, talk to your doctor or nurse before you are given Terlipressin Acetate.
Please check with your doctor before Terlipressin Acetate is given to you if you:
If any of the above apply to you (or you are not sure) talk to your doctor or nurse before you are given Terlipressin Acetate.
Please tell your doctor or nurse if you are taking or have recently taken any other medicines. This includes medicines obtained without a prescription, including herbal medicines. Terlipressin Acetate can affect the way some other medicines work. Also some other medicines can affect the way Terlipressin Acetate works.
Please inform your doctor immediately if you take any of the following medicines
Drugs that can trigger irregular beating of the heart (arrhythmia) such as the following:
Ask your doctor, nurse or pharmacist for advice before taking any medicine if you are pregnant or breast‑feeding.
Terlipressin Acetate is used in hospitals and will be given to you by a doctor or nurse. Terlipressin Acetate will be given to you as an injection into a vein.
During treatment, your blood pressure, serum sodium and potassium and fluid balance will be monitored closely.
Like all medicines, Terlipressin Acetate can cause side effects, although not everybody gets them.
Very commonly reported side effects (may affect more than 1 in 10 people treated):
Commonly reported side effects (affect less than 1 in 10 people):
Uncommon reported side effects (may affect up to 1 in 100 people):
Not known: frequency cannot be estimated from the available data
Reporting of side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children. Do not use Terlipressin Acetate after the expiry date which is stated on the pack. The expiry date refers to the last day of that month. Store in a refrigerator at 2-8ºC.
Keep the ampoules in the outer carton in order to protect from light.
Terlipressin Acetate is a clear, colourless solution for injection. It is available in one pack size of 5 ampoules with 8.5 ml of solution in each ampoule.
Terlipressin Acetate 0.12 mg/ml Solution for injection – PL 03194/0101
This leaflet was last revised in December 2023.
5009001914
Drayton Hall, Church Road, West Drayton, UB7 7PS, UK
+44 (0)844 931 0051
http://www.ferring.co.uk
+44 (0)844 931 0050
0800 111 4125